Cancer portrays a colossal range of infections that all begin from uncontrolled cell development. Comprehensively separated into bening tumors (incapable to metastasize) or malignant tumors (ready to attack typical tissues), malignant growths are additionally characterized and arranged by their cell type, tissue, or organ of cause. Malignancy remains the number two reason for death in the U.S., second just to coronary illness, and the Intramural Research Program (IRP) is focused on propelling exploration, building aptitude, and utilizing assets to address this worldwide test. Our researchers are continually getting familiar with the reasons for malignant growth, and growing new and better approaches to forestall, distinguish, and treat it.
Case Report: Journal of Cancer Clinical Trials
Case Report: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report